The India Fertility Services Market has emerged as a key healthcare segment, fueled by rising infertility, technology adoption, and increasing societal acceptance. The market size was estimated at USD 1.5 billion in 2024, with projections to exceed USD 9 billion by 2035.

Fertility services include advanced ART procedures and infertility drugs, offering diverse solutions for patients. Female infertility continues to dominate the market, while male infertility is growing due to greater awareness. Expanding fertility clinics in urban and semi-urban areas enhance service accessibility.

Major market players focus on technology integration, partnerships, and service expansion to meet rising demand. Telemedicine, personalized treatment plans, and AI-based solutions offer significant future growth opportunities. Despite challenges such as treatment costs and regulatory concerns, the market outlook remains robust.